BACE1 and Alzheimer disease: Previous studies have confirmed that ICA has multiple regulatory pathways in AD pathology, including the BACE1, NO/cyclic guanosine monophosphate (cGMP), Wnt/Ca2+, and PI3K/Akt signaling pathways.